| __timestamp | Ligand Pharmaceuticals Incorporated | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 64538000 | 9757000 |
| Thursday, January 1, 2015 | 71914000 | 1253000 |
| Friday, January 1, 2016 | 108973000 | 5421000 |
| Sunday, January 1, 2017 | 141102000 | 154584000 |
| Monday, January 1, 2018 | 251453000 | 301034000 |
| Tuesday, January 1, 2019 | 120282000 | 380833000 |
| Wednesday, January 1, 2020 | 186419000 | 540099000 |
| Friday, January 1, 2021 | 277133000 | 701887000 |
| Saturday, January 1, 2022 | 196245000 | 933013000 |
| Sunday, January 1, 2023 | 131314000 | 1243336000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Sarepta Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated have demonstrated contrasting trajectories. From 2014 to 2023, Sarepta's revenue skyrocketed by over 12,600%, reaching approximately $1.24 billion in 2023. This remarkable growth underscores Sarepta's strategic advancements in gene therapy and rare disease treatments.
Conversely, Ligand Pharmaceuticals experienced a more modest revenue increase of around 103% during the same period, peaking at $277 million in 2021. Ligand's steady growth reflects its focus on drug discovery and licensing partnerships. The data highlights a pivotal shift in the biotech sector, where innovation and strategic alliances drive financial success. As the industry evolves, these companies exemplify diverse paths to achieving revenue milestones.
Revenue Showdown: Eli Lilly and Company vs Sarepta Therapeutics, Inc.
Annual Revenue Comparison: Amgen Inc. vs Sarepta Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Exelixis, Inc. Performance Compared
Breaking Down Revenue Trends: Sarepta Therapeutics, Inc. vs Jazz Pharmaceuticals plc
Sarepta Therapeutics, Inc. vs Mesoblast Limited: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Travere Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or Galapagos NV?
Annual Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
TG Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated